Business Context and Reporting Period
This Form 8-K Current Report was filed by Alector, Inc. on October 5, 2022, covering the event date of October 3, 2022. The filing addresses Item 5.02 regarding the departure of a senior officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements.
Material Changes
The material change reported is the resignation of Robert King, Ph.D., who served as the Company's Chief Development Officer. His resignation is effective October 28, 2022, to pursue another professional opportunity.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the personnel change. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the effective date of Robert King's resignation (October 28, 2022).
- Confirm if a successor for the Chief Development Officer role has been appointed or if the role will be restructured.
- Review subsequent filings for any impact on the Company's clinical development pipeline or strategic direction.